Charles Schwab stock initiated with Outperform rating at BMO Capital

BMO Capital initiated coverage on Charles Schwab (NYSE:SCHW) with an Outperform rating and a $110 price target, citing balance sheet healing and potential for improved capital efficiency through a 'bank-lite strategy.' This positive outlook is supported by strong recent performance, including $44.4 billion in core net new assets and $11.23 trillion in total client assets, which also prompted Truist Securities to reiterate its Buy rating. Schwab is further signaling strategic growth through branch network expansion and an upcoming Fall Business Update for institutional investors.

Analysis

BMO Capital has initiated coverage on Charles Schwab Corp. (SCHW) with an Outperform rating and a $110 price target, signaling confidence primarily driven by the company's balance sheet healing. However, BMO notes this improvement is largely factored into current consensus estimates and that earnings per share growth is expected to slow once wholesale funding is paid down. The firm's core thesis highlights a significant opportunity for improved capital efficiency through a potential "bank-lite strategy," which could enhance the company's valuation. This bullish analyst sentiment is supported by strong operational metrics, including a 35% year-over-year increase in core net new assets to $44.4 billion for August 2025, and total client assets reaching $11.23 trillion. These results have also prompted Truist Securities to reiterate its Buy rating with a $112 price target. Schwab is actively pursuing growth, evidenced by its plans to expand its branch network, hire over 400 new staff, and host an institutional investor update on October 16, reinforcing its strategic initiatives.

Key Decisions for Investors

• Investors could interpret the new 'Outperform' rating from BMO and reiterated 'Buy' from Truist, alongside strong asset growth of 35% YoY, as a strong signal to consider or add to long positions in SCHW.
• It is crucial to monitor the upcoming October 16 investor update for any management commentary on capital efficiency improvements, particularly the 'bank-lite' concept, as this could serve as the next major valuation catalyst.
• While the outlook is positive, investors should remain aware that BMO sees the balance sheet recovery as largely priced-in and expects slowing EPS growth, suggesting the primary investment thesis is now shifting towards long-term organic growth and capital strategy execution.